rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Sarabjit Kour Nangra

Rediff.com  »  News  »   Sarabjit Kour Nangra

  News for Sarabjit Kour Nangra

  • Business

Markets clock highest gain since Oct on US Fed stance

Indian equity markets registered their highest single-day percentage gains since early October on across-the-board buying tracking a rally in global stocks after the minutes of the US Federal......

Dr Reddy's gets warning from US health regulator

Pharmaceutical major Dr Reddy’s Laboratories has received a warning letter from the US Food and Drug Administration (FDA) over quality control issues at three of its manufacturing......

Lupin acquires US generics firm GAVIS for $880 mn

  Deal marks the largest acquisition by an Indian pharma company in the US In its fifth foreign acquisition within 18 months, Lupin on Thursday said it would acquire New Jersey-based generic......

Infosys bets on new services to push sales to $20 bn by 2020

Infosys has been making bets on automation and other high-margin services like artificial intelligence to regain some ground Infosys Ltd, India's second-largest software services exporter, on......

Strong dollar dents Indian IT companies' revenues

The dollar's biggest quarterly rise against other major currencies since 2008 has undermined sales of India's IT services firms in non-U.S. markets, including Europe, in what was already a......
  Web results for Sarabjit Kour Nangra
The Right Path To Good Health?

Advertisement Weighing the importance of medical discovery, providing broad healthcare solutions and understanding market needs is not an... ...

http://www.businessworld.in/article/The-Right-Path-To-Good-Health-/12-02-2016-91078
Cipla reports a 4.7% increase in Q3 FY15-16 results

Drug major Cipla on Wednesday, on Feb. 10, 2016,announced its unaudited consolidated financial results for the quarter ended Dec. 31, 2015. They... ...

http://www.ibtimes.co.in/cipla-reports-4-7-increase-q3-fy15-16-results-666480
8 firms buck the trend, manage steller third-quarter earnings

Third-quarter earnings have been dismal for most of the companies. But eight firms managed to buck the trend and forge ahead due to strong... ...

http://economictimes.indiatimes.com/markets/stocks/news/8-firms-buck-the-trend-manage-steller-third-quarter-earnings/articleshow/50923581.cms
Dr Reddy's posts Rs579.2 crore Q3 net profit, misses analysts estimates

crore from Rs3,843.1 crore in the previous year Dr. Reddy's Laboratories Ltd, India's second largest drug maker by net sales, reported on Tuesday a... ...

http://www.livemint.com/Companies/D3QfqOYyMetftIuh3rY4ZN/DrReddys-posts-Rs5792-crore-net-profit-misses-analysts-e.html
Dr Reddy's shares closes nearly 4% down on weak Q3 result

Shares of Dr Reddy's Laboratories on Tuesday fell by nearly 4% after the company's December quarter earnings failed to meet market expectations.... ...

http://www.dnaindia.com/money/report-dr-reddy-s-shares-closes-nearly-4-down-on-weak-q3-result-2175845

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z